The Resistant Starch Intervention for Cognitive Enhancement
Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY ·
Trial Information
Current as of September 12, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether eating foods high in resistant starch—a type of carbohydrate that resists digestion—can help slow down memory and thinking problems in people who have a higher genetic risk for cognitive decline. Participants will be split into two groups: one will eat foods with a lot of resistant starch every day, while the other will eat similar foods with regular starch. The study will look at changes in thinking skills and brain health using memory tests, blood and stool samples, and brain scans to understand how resistant starch might protect the brain.
The study is open to adults of all genders who are at higher genetic risk for cognitive problems, though specific age details are still to be confirmed. If you join, you’ll be asked to follow the diet assigned to you and take part in several tests and scans over time. This research is not yet recruiting participants, but it aims to find out if a simple dietary change could help keep the brain healthier for longer in people at risk.
Gender
ALL
Eligibility criteria
About Second Affiliated Hospital, School Of Medicine, Zhejiang University
The Second Affiliated Hospital of Zhejiang University School of Medicine is a leading clinical research institution dedicated to advancing healthcare through innovative medical practices and rigorous scientific inquiry. With a robust infrastructure and a multidisciplinary team of experienced researchers and clinicians, the hospital is committed to conducting high-quality clinical trials that address critical health challenges. As an integral part of Zhejiang University, the hospital leverages academic expertise and cutting-edge technology to foster collaboration in research, education, and patient care, ultimately aiming to improve patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported